The company has this week entered into a cannabis concentrate program agreement with a Canadian company.
Newswires
Showing 25 of 159
TSX Venture Exchange-listed MediPharm Labs Inc will have its medicinal and recreational products distributed by a large-scale licensed producer.
The company is increasing the capacity of its hemp-derived cannabidiol production facility in the US.
Roots marries its RZTO technology with the nutrient film technique technology of Teshuva Agricultural Projects at Israeli operation.
The company recently appointed Canadian Luke Pigeau as master grower.
The C$5 million investment gives MMJ a 6.9% interest in MediPharm Labs Inc.
The company’s RZTO technology will be piloted in an open field growing scenario in Washington State.
Canada will be the largest developed nation to legalise nationwide recreational use.
eSense is aiming to commercialise its formulations into the global e-cigarette liquid market.
CannPal is researching the benefits of medical cannabis for companion animals.
The trial will test the safety, efficacy and dose tolerance in cancer patients.
Shares in the company were halted having last traded at 61 cents.
Cann is scaling up substantially to compete on the global medicinal cannabis stage.
The trading halt has been granted pending the release of results from the EGM today.
An important proposed change for MMJ’s largest investment, Harvest One Cannabis Inc.
Medlab developed the nanoparticle medicine delivery system, Nanocelle.
Algae.Tec has signed a deal with a private Australian-based pharmaceutical delivery company.
Three directors participate in oversubscribed share purchase plan.
NanaBis is a mouth spray and will be clinically tested in advanced stage cancer patients.
Funds raised through the share purchase plan will drive growth in Australia and Canada.
Manuka to develop, manufacture and supply a hemp-based, high methylglyoxal product.
The new collaboration will develop research and technical capabilities.
Changes to regulations in Australia have opened the door for cannabis breeders.
The halt will remain in place until Wednesday 17th January 2018.
The new appointment has experience with investments in medicinal cannabis.
